December 27, 2018
The Ministry of Health, Labor and Welfare (MHLW) granted orphan designation for ReproCELL’s adipose-derived mesenchymal stem cell therapy SB-ADSC-01 for preventing the progression of clinical symptoms associated with spinocerebellar ataxia. The orphan status was endorsed by the Pharmaceutical Affairs and...read more